Acrivon Therapeutics
ACRV
#9727
Rank
โ‚ฌ44.83 M
Marketcap
1,42ย โ‚ฌ
Share price
12.00%
Change (1 day)
-72.96%
Change (1 year)

Earnings for Acrivon Therapeutics (ACRV)

Earnings in 2025 (TTM): -โ‚ฌ80 Million

According to Acrivon Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ75.45 Million a decrease over its 2023 earnings that were of -โ‚ฌ56.76 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Acrivon Therapeutics from 2022 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ80 Million6.03%
2024 -โ‚ฌ75.45 Million32.93%
2023 -โ‚ฌ56.76 Million105.48%
2022 -โ‚ฌ27.63 Million